First Page | Document Content | |
---|---|---|
Anticoagulants Coagulation system Bristol-Myers Squibb Heparins Sanofi Rivaroxaban Apixaban Dabigatran Prothrombinase Chemistry Organic chemistry Hematology | Mueck et al. Thrombosis Journal 2013, 11:10 http://www.thrombosisjournal.com/contentREVIEW Open AccessAdd to Reading ListSource URL: www.thrombosisjournal.comDownload Document from Source WebsiteFile Size: 624,42 KBShare Document on Facebook |
PDF DocumentDocID: 1vWaT - View Document | |
Press release Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi DocID: 1vq21 - View Document | |
Press release Ipsen completes acquisition of select Consumer Healthcare products from Sanofi Paris (France), 8 May 2017 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has completed its previously announceDocID: 1vnbG - View Document | |
SANOFI WELCOMES House Policy Coucus KEY FACTS & FIGURES sANoFtDocID: 1v7jN - View Document | |
A GLOBAL HEALTHCARE COMPANY We are Sanofi CORPORATE PRESENTATION | JUNEDocID: 1uQ20 - View Document |